# Elevage


## Posts

- [Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor](https://elevagemedical.com/biobeat-secures-50-million-series-b-financing-to-advance-commercialization-of-its-patch-worn-cuff-less-24-hour-ambulatory-blood-pressure-monitor/): Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of hypertension, announced today the closing of a $50 million Series B equity financing. The time has arrived to make ABPM a true standard of care. Biobeat secures $50M to […]
- [SetPoint System - An implant to treat an autoimmune disease](https://elevagemedical.com/setpoint-system-an-implant-to-treat-an-autoimmune-disease/): SetPoint Medical is offering patients with the autoimmune disorder rheumatoid arthritis something close to a cure. The company’s SetPoint System—which was FDA approved in July—is a small neck implant that gives an electrical jolt for one minute a day to the vagus nerve, and has been shown to help regulate the body’s immune response. “This […]
- [Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease](https://elevagemedical.com/galvanize-therapeutics-raises-100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease/): Sofinnova Partners leads premier investor syndicate backing Galvanize’s breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach targeting solid tumors and chronic bronchitis, the leading cause of COPD. Galvanize (“Galvanize”) Therapeutics, Inc, a commercial-stage medical technology company pioneering pulsed electric field (PEF) therapies for oncology and chronic lung disease successfully raised an oversubscribed $100 million Series C […]
- [New Implant Offers Hope forEasing Rheumatoid Arthritis](https://elevagemedical.com/new-implant-offers-hope-foreasing-rheumatoid-arthritis/): The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease. The Food and Drug Administration on Wednesday approved a medical device that offers new hope to patients incapacitated by rheumatoid arthritis, a chronic condition that afflicts 1.5 million Americans and is often resistant to treatment. The […]
- [SetPoint Medical Raises $140 Million in Private Financing and Expands Leadership Team to Support Commercialization of Rheumatoid Arthritis Therapy](https://elevagemedical.com/setpoint-medical-raises-140-million-in-private-financing-and-expands-leadership-team-to-support-commercialization-of-rheumatoid-arthritis-therapy/): VALENCIA, Calif.–(BUSINESS WIRE)–SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, announced that it has raised $140 million in private financing, that includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical Technologies […]
- [FIRE1 Secures $120 Million Financing to Revolutionize Heart Failure Care](https://elevagemedical.com/fire1-secures-120-million-financing-to-revolutionize-heart-failure-care/): FDA awards Breakthrough Device Designation to FIRE1’s Norm™ system DUBLIN–FIRE1, a leading connected medical device solutions company, today announced the successful completion of a $120 million financing round to accelerate the company’s mission to transform the lives of millions of people living with heart failure. FIRE1’s Norm™ heart failure management system offers a groundbreaking approach […]
- [4basebio Plc - Completion of Strategic Investment](https://elevagemedical.com/4basebio-plc-completion-of-strategic-investment/): This Announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation No. 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended (“EUWA“) and as it may be modified from time to time by or under domestic law including, but not limited to, by the Market Abuse (Amendment) (EU […]
- [Nuclera closes $75 million USD financing](https://elevagemedical.com/nuclera-closes-75-million-usd-financing/): Cambridge, UK, and Boston MA, USA, 16 October 2024: Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million). The fundraise was led by Elevage Medical Technologies, backed by Patient Square Capital, and joined by British Patient Capital, […]
- [Moximed Completes Closing of Series D Financing for $91 Million to Accelerate Commercialization of MISHA® Knee System, an Implantable Shock Absorber for Knee Osteoarthritis](https://elevagemedical.com/moximed-completes-closing-of-series-d-financing-for-91-million-to-accelerate-commercialization-of-misha-knee-system-an-implantable-shock-absorber-for-knee-osteoarthritis/): New investor Elevage Medical Technologies leads funding round with Cormorant Asset Management and Warren Point Capital joining the investor syndicate FREMONT, Calif.–(BUSINESS WIRE)–Moximed, an innovative medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced the closing on $61 million of Series D preferred stock […]
- [Elevage Medical Technologies Continues Expansion of Investment Team and Board](https://elevagemedical.com/elevage-medical-technologies-continues-expansion-of-investment-team-and-board/): Firm adds to its team with a new Board Member and two new V.P. hires AUSTIN, Texas, Feb. 27, 2024 /PRNewswire/ — Elevage Medical Technologies (“Elevage”), a portfolio company of Patient Square Capital, dedicated to supporting growth-stage medical device and medical technology companies, today announced key additions to the investment team and board. Vice-Presidents Suchira Sharma and Peter […]
- [Elucid Raises $80 Million in Series C Round Led by Elevage Medical Technologies](https://elevagemedical.com/elucid-raises-80-million-in-series-c-round-led-by-elevage-medical-technologies/): Investment will drive commercialization and expansion of AI-powered non-invasive diagnostic tools to help evaluate cardiovascular risk BOSTON–(BUSINESS WIRE)– Elucid, a leading medical technology company providing physicians with AI-powered imaging analysis software to assess cardiovascular disease, today announced it has raised $80 million in Series C funding. The round was led by Elevage Medical Technologies, with additional participation […]
- [Patient Square Capital Announces Formation of Elevage Medical Technologies to Partner with Growth-Stage Medical Device Companies](https://elevagemedical.com/patient-square-capital-announces-formation-of-elevage-medical-technologies-to-partner-with-growth-stage-medical-device-companies/): $300 million investment commitment from Patient Square Capital MENLO PARK, CA, May 1, 2023 – Patient Square Capital (“Patient Square”), a leading health care investment firm, today announced the formation of Elevage Medical Technologies (“Elevage”), a new portfolio company to support the growth of promising medical device companies by providing capital and deep strategic expertise. Elevage will […]

## Pages

- [Jae Yoon](https://elevagemedical.com/team/jae-yoon/): Jae Yoon Jae Yoon Associate Jae Yoon is an Associate at Elevage. Most recently, he was a consultant at McKinsey & Company, where he focused on the healthcare industry, advising on growth strategies and conducting due diligences. Jae holds a B.A. in Neuroscience from the University of Pennsylvania. Return to Team
- [Steve Whitlock](https://elevagemedical.com/team/steve-whitlock/): Steve Whitlock Steve Whitlock Elevage Senior Advisor Steve has over 20 years of orthopedics industry experience, in addition to being a co-founder of Path4 Ventures and an Operating Venture Partner with PTV Sciences. During his tenure working in the venture space he co-founded Spinal Restoration and LDR Spine USA where he served as President. Steve […]
- [Jim Henry](https://elevagemedical.com/team/jim-henry/): Jim Henry Jim Henry Elevage Senior Advisor Jim brings over 37 years of financial accounting experience from PricewaterhouseCoopers LLC (PwC), where he held numerous leadership and senior client roles, including Global Healthcare Leader, Vice Chair – Industries & Sectors, and Managing Partner for the San Francisco area. As Healthcare Leader, Mr. Henry led the growth […]
- [Stuart Kurlander](https://elevagemedical.com/team/stuart-kurlander/): Stuart Kurlander Stuart Kurlander Patient Square Senior Advisor Stuart Kurlander is a Senior Advisor to Patient Square Capital and former Global Co-Chair of the Healthcare & Life Sciences Practice and Global Co-Chair of the Israel Practice at Latham & Watkins. Mr. Kurlander founded and built Latham & Watkins’ preeminent Healthcare & Life Sciences Practice in […]
- [Colin Shannon](https://elevagemedical.com/team/colin-shannon/): Colin Shannon Colin Shannon Patient Square Senior Advisor Colin Shannon is a Senior Advisor to Patient Square Capital and former Chairman and Chief Executive Officer at PRA Health Sciences. Prior to PRA Health Sciences, Mr. Shannon held various executive roles at Pharmaceutical Product Development Inc. (PPD), including Executive Vice President of Global Clinical Operations. Other […]
- [Stephen Oesterle, M.D.](https://elevagemedical.com/team/stephen-oesterle/): Stephen Oesterle Stephen Oesterle, M.D. Patient Square Senior Advisor Dr. Stephen Oesterle is a Senior Advisor to Patient Square Capital and former SVP of Medicine and Technology for Medtronic, Plc., where he oversaw long term internal technology development whilst participating in strategic corporate investments in emerging private health care companies. Most recently, Dr. Oesterle has […]
- [Bob McDonald](https://elevagemedical.com/team/bob-mcdonald/): Dr. Robert McDonald Dr. Robert McDonald Elevage Senior Advisor Bob has 30 years experience as a physician leader in reimbursement consulting with healthcare insurance and pharma expertise. Currently, he is the President and Founder of Aledo Consulting, Inc. Prior to this role, he served in a variety of senior medical and operations positions at Anthem […]
- [Jim Mazzo](https://elevagemedical.com/team/jim-mazzo/): Jim Mazzo Jim Mazzo Patient Square Advisor James V. (Jim) Mazzo is an Industry Advisor to Patient Square Capital. Mr. Mazzo is Executive Chair of Neurotech, a private clinical stage biotech company focused on developing transformative therapies for chronic retinal diseases. He sits on the Boards of Emmecell, Iantrek, Visus, Pulse Medica, Signal 12, Remonihealth […]
- [News](https://elevagemedical.com/news/): Latest News Stay informed on our latest investments, partner companies updates and industry insights November 4, 2024 Nuclera’s eProtein Discovery System Installed at Domainex to Streamline Protein Production Services CAMBRIDGE, England, November 04, 2024–(BUSINESS WIRE)–Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider […]
- [Partner Companies](https://elevagemedical.com/partner-companies/): Partner Companies Elucid offers histologically-validated, non-invasive CTA-based software for arterial analysis, enhancing cardiovascular disease diagnosis and treatment with precise, personalized care through its PlaqueIQ technology. Visit Website Moximed’s MISHA Knee System is an implantable shock absorber designed to relieve pain and improve function in patients with medial knee OA, offering quick recovery and an alternative […]
- [Contact](https://elevagemedical.com/contact/): Contact Office Address 3308 Rogers Road, Unit 6101, Austin, Texas 78758 Mail Address 3571 Far West Blvd, Suite 108 Austin, TX 78731 Email admin@elevagemedical.com Contact us Connect with the Elevage Medical Technologies team today. Subscribe to Our Newsletter
- [Josh Makower , M.D.](https://elevagemedical.com/team/josh-makower/): Josh Makower Josh Makower , M.D. Senior Advisor & Board Member Josh Makower, M.D. is the Yock Family Professor of Medicine and Bioengineering at the Stanford University Schools of Medicine and Engineering, and is the Director and Co-Founder of the Stanford Byers Center for Biodesign. Josh is the Founder and Executive Chairman of ExploraMed, a […]
- [Hannah Carlino](https://elevagemedical.com/team/hannah/): Hannah Carlino Hannah Carlino Board Member, Patient Square Vice President Hannah Carlino is a Deal Professional Vice President at Patient Square Capital. Prior to joining Patient Square, Ms. Carlino was an Associate at Golden Gate Capital. Earlier in her career, she was an Analyst in the health care group of the Investment Banking Division at […]
- [Laura Furmanski , Ph.D.](https://elevagemedical.com/team/laura-furmanski/): Laura Furmanski Laura Furmanski , Ph.D. Board Member, Elevage Medical Technologies Partner, Patient Square Capital Head of Patient Square Insights Laura Furmanski, Ph.D. is a Partner at Patient Square Capital and Head of Patient Square Insights and a member of the board of Elevage Medical Technologies, Enavate Sciences and Apollo Therapeutics. Dr. Furmanski has 20 […]
- [Neel Varshney , M.D.](https://elevagemedical.com/team/neel-varshney/): Neel Varshney Neel Varshney , M.D. Board Member, Elevage Medical Technologies Founding Partner, Patient Square Capital Neel Varshney, M.D. is a Founding Partner of Patient Square Capital. He has over 18 years of investment and health care experience. Prior to Patient Square, Dr. Varshney was a Managing Director on KKR’s Americas Health Care Team, where […]
- [Jim Momtazee](https://elevagemedical.com/team/jim-momtazee/): Jim Momtazee Jim Momtazee Chairman of the Board of Directors, Elevage Medical Technologies Managing Partner, Patient Square Jim Momtazee is the Managing Partner of Patient Square Capital. Mr. Momtazee has 27 years of investment and acquisition experience, the vast majority of which was focused on the health care sector. Prior to Patient Square, he spent […]
- [Suchira Sharma](https://elevagemedical.com/team/suchira-sharma/): Suchira Sharma Suchira Sharma Principal Suchira is a Principal at Elevage, with a background in healthcare equity and credit. Most recently Suchira was a member of the investment team at Revelation Partners, managing $1.5 billion in AUM. Prior to Revelation, she was a member of the Life Sciences team at Hercules Capital, where she underwrote […]
- [Michael Wasserman , Ph.D.](https://elevagemedical.com/team/michael-wasserman/): Michael Wasserman Michael Wasserman , Ph.D. Chief Operating Officer & Partner Michael Wasserman, Ph.D. is a Partner and COO of Elevage. Michael has over 30 years of experience in healthcare as a scientist, entrepreneur, executive, and investor. Prior to Elevage, Michael served as Managing Partner of Maverix Private Equity. Michael spent 17 years at H.I.G. […]
- [Evan Melrose , M.D. , M.B.A.](https://elevagemedical.com/team/evan-melrose/): Evan Melrose Evan Melrose , M.D. , M.B.A. Chief Executive Officer & Partner Elevage Medical Technologies is led by Evan Melrose, M.D., M.B.A., an accomplished health care executive and physician, with more than 27 years of experience across clinical, investment, and governance roles. Dr. Melrose most recently served as the Founding Managing Director of Spindletop […]
- [Team](https://elevagemedical.com/team/): Our Team Meet Our Team Evan Melrose , M.D. , M.B.A. Chief Executive Officer & Partner Michael Wasserman , Ph.D. Chief Operating Officer & Partner Suchira Sharma Principal Stacy Brown Business Manager Jae Yoon Associate Josh Makower , M.D. Senior Advisor & Board Member Jim Momtazee Chairman of the Board of Directors Neel Varshney , […]
- [Home](https://elevagemedical.com/): Fueling Life-ChangingMedical Technologies Our Commitment Elevage Medical Technologies is dedicated to supporting medical technology companies, including devices, tools, diagnostics, and tech-enabled services that can meaningfully improve health outcomes and quality of life for patients. Through capital investment and strategic operational support, Elevage strives to accelerate the pace of innovation in the medical technology space. We […]


[comment]: # (Generated by Hostinger Tools Plugin)